Header Logo

Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab).

Elmallah MK, Hendeles L, Hamilton RG, Capen C, Schuler PM. Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab). J Pediatr Pharmacol Ther. 2012 Jan; 17(1):88-92.

View in: PubMed